Ole S. Nielsen

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

Allan T. van Oosterom, Ian Judson, Jaap Verweij et al. · The Lancet · 2001 · 1.3K citations

Oncology, Gastrointestinal Oncology, Medicine +5

Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial

Axel Le Cesne, Jean‐Yves Blay, Ian Judson et al. · Journal of Clinical Oncology · 2005 · 418 citations

Imatinib mesylate (STI-571 Glivec®, Gleevec™) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target

Jaap Verweij, A. van Oosterom, Jean‐Yves Blay et al. · European Journal of Cancer · 2003 · 402 citations

Oncology, Gastrointestinal Oncology, Molecular Target +10

Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients

A.N. van Geel, Ugo Pastorino, K. W. Jauch et al. · Cancer · 1996 · 283 citations

Surgical Oncology, Lung Metastases, Ewing Sarcoma +13

Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group

Allan T. van Oosterom, Ian Judson, Jaap Verweij et al. · European Journal of Cancer · 2002 · 234 citations

Tumoral Pathology, Bone Sarcoma Group, Gastrointestinal Oncology +8